Header cover image

Pharmaceuticals & Biotech Consumer Discretionary

Results

1272

0 new

All the companies in the consumer discretionary sector including household durables, leisure products and luxury goods.

1,272 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

ANVS

Annovis Bio
US$8.060.7%-11.4%US$105.7mUS$37.25PE-2.4xE-2.5%n/a

RGLS

Regulus Therapeutics
US$1.57-4.6%13.8%US$105.4mUS$10.33PB1xE35.9%n/a

OPTN

OptiNose
US$0.67-6.9%-43.7%US$105.4mUS$3.50PS1.3xE66.5%n/a

ETTX

Entasis Therapeutics Holdings
US$2.190%-14.8%US$104.8mUS$2.00PB6.3xE52.3%n/a

JUSH.F

Jushi Holdings
US$0.531.6%-41.7%US$104.2mUS$1.50PE-1.8xE36.5%n/a

ALXO

ALX Oncology Holdings
US$1.82-8.5%-62.2%US$103.8mUS$9.27PB0.6xE8.1%n/a

LPTX

Leap Therapeutics
US$2.57-5.2%97.7%US$103.3mUS$11.38PB1.5xE5.2%n/a

COYA

Coya Therapeutics
US$6.459.9%65.4%US$102.9mUS$15.63PS10.3xE-36.1%n/a

ANIX

Anixa Biosciences
US$3.15-2.5%4.3%US$102.7mUS$8.50PB4.7xE-7.9%n/a

TLSA

Tiziana Life Sciences
US$0.96-5.9%45.5%US$102.5mn/aPB17.6xn/an/a

LRTX

Lirum Therapeutics
US$11.00n/an/aUS$102.0mn/aPB42.7xn/an/a

RLMD

Relmada Therapeutics
US$3.24-7.4%6.2%US$101.7mUS$12.50PB1.6xE5.6%n/a

MRNS

Marinus Pharmaceuticals
US$1.8412.9%-75.6%US$101.4mUS$6.89PS3.3xE64.6%n/a

CKPT

Checkpoint Therapeutics
US$2.24-5.1%39.1%US$101.3mUS$17.00PS1292.8xE83.9%n/a

MIST

Milestone Pharmaceuticals
US$1.52-1.0%-49.0%US$101.3mUS$10.25PB3.1xE61.8%n/a

ORMP

Oramed Pharmaceuticals
US$2.444.9%-5.1%US$101.1mUS$3.25PE4.8xE-151.6%n/a

ASMB

Assembly Biosciences
US$15.14-6.9%48.4%US$100.2mUS$35.50PS4.5xE-22.1%n/a

CTOR

Citius Oncology
US$1.39-23.6%-87.1%US$99.8mn/aPB5.8xn/an/a

CELL

PhenomeX
US$1.000.5%-68.2%US$99.6mUS$1.00PS1.4xE38.2%n/a

ADAG

Adagene
US$2.22-1.3%55.2%US$99.1mUS$9.15PS120.5xE-10.5%n/a

ELDN

Eledon Pharmaceuticals
US$2.49-2.4%60.6%US$98.7mUS$14.00PE-3.1xE-20.1%n/a

MDXH

MDxHealth
US$2.08-21.4%-24.4%US$97.9mUS$6.80PS1.2xE48.7%n/a

BLUE

bluebird bio
US$0.526.3%-82.3%US$97.8mUS$2.75PS1.8xE38.0%n/a

CBUS

Cibus
US$3.26-8.3%-82.2%US$96.3mUS$19.13PS28.2xE47.4%n/a
Page 21 of 53
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.